Forecasting individual risk for long-term Posttraumatic Stress Disorder in emergency medical settings using biomedical data: A machine learning multicenter cohort study.

Biomarkers HPA axis Machine learning PTSD Pharmacotherapy Prognosis Thyroid hormones Traumatic stress

Journal

Neurobiology of stress
ISSN: 2352-2895
Titre abrégé: Neurobiol Stress
Pays: United States
ID NLM: 101643409

Informations de publication

Date de publication:
May 2021
Historique:
received: 20 10 2020
revised: 22 12 2020
accepted: 12 01 2021
entrez: 8 2 2021
pubmed: 9 2 2021
medline: 9 2 2021
Statut: epublish

Résumé

The necessary requirement of a traumatic event preceding the development of Posttraumatic Stress Disorder, theoretically allows for administering preventive and early interventions in the early aftermath of such events. Machine learning models including biomedical data to forecast PTSD outcome after trauma are highly promising for detection of individuals most in need of such interventions. In the current study, machine learning was applied on biomedical data collected within 48 h post-trauma to forecast individual risk for long-term PTSD, using a multinominal approach including the full spectrum of common PTSD symptom courses within one prognostic model for the first time. N = 417 patients (37.2% females; mean age 46.09 ± 15.88) admitted with (suspected) serious injury to two urban Academic Level-1 Trauma Centers were included. Routinely collected biomedical information (endocrine measures, vital signs, pharmacotherapy, demographics, injury and trauma characteristics) upon ED admission and subsequent 48 h was used. Cross-validated multi-nominal classification of longitudinal self-reported symptom severity (IES-R) over 12 months and bimodal classification of clinician-rated PTSD diagnosis (CAPS-IV) at 12 months post-trauma was performed using extreme Gradient Boosting and evaluated on hold-out sets. SHapley Additive exPlanations (SHAP) values were used to explain the derived models in human-interpretable form. Good prediction of longitudinal PTSD symptom trajectories (multiclass AUC = 0.89) and clinician-rated PTSD at 12 months (AUC = 0.89) was achieved. Most relevant prognostic variables to forecast both multinominal and dichotomous PTSD outcomes included acute endocrine and psychophysiological measures and hospital-prescribed pharmacotherapy. Thus, individual risk for long-term PTSD was accurately forecasted from biomedical information routinely collected within 48 h post-trauma. These results facilitate future targeted preventive interventions by enabling future early risk detection and provide further insights into the complex etiology of PTSD.

Identifiants

pubmed: 33553513
doi: 10.1016/j.ynstr.2021.100297
pii: S2352-2895(21)00005-9
pmc: PMC7843920
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100297

Informations de copyright

© 2021 The Authors.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Psychoneuroendocrinology. 2006 Nov;31(10):1220-30
pubmed: 17081699
Am J Psychiatry. 2020 Jan 1;177(1):58-65
pubmed: 31352811
Clin Psychol Rev. 2016 Nov;49:79-91
pubmed: 27623149
Lancet. 1974 Jul 13;2(7872):81-4
pubmed: 4136544
J Trauma. 1974 Mar;14(3):187-96
pubmed: 4814394
N Engl J Med. 2017 Jun 22;376(25):2459-2469
pubmed: 28636846
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
PLoS One. 2014 May 09;9(5):e97183
pubmed: 24816642
Biol Psychiatry. 2012 Feb 15;71(4):309-16
pubmed: 22137507
Biol Psychiatry. 2018 May 15;83(10):866-875
pubmed: 29628193
Psychiatr Ann. 2016 Mar;46(3):173-176
pubmed: 27773950
Transl Psychiatry. 2017 Mar 21;7(3):e0
pubmed: 28323285
Psychoneuroendocrinology. 2014 Jul;45:179-86
pubmed: 24845188
JAMA Psychiatry. 2017 Feb 1;74(2):135-142
pubmed: 28002832
Cochrane Database Syst Rev. 2014 Jul 08;(7):CD006239
pubmed: 25001071
Front Psychiatry. 2018 Nov 06;9:558
pubmed: 30459654
JMIR Ment Health. 2019 Jul 22;6(7):e13946
pubmed: 31333201
World Psychiatry. 2019 Feb;18(1):77-87
pubmed: 30600620
Neurobiol Stress. 2016 Sep 08;6:57-67
pubmed: 28229109
BMC Psychiatry. 2015 Mar 16;15:30
pubmed: 25886446
J Trauma Stress. 2019 Apr;32(2):215-225
pubmed: 30892723
Chronic Stress (Thousand Oaks). 2019 Jan-Dec;3:
pubmed: 31179413
Lancet. 2006 May 6;367(9521):1533-40
pubmed: 16679167
Clin Psychol Rev. 2018 Jul;63:41-55
pubmed: 29902711
Brain Inj. 2001 Oct;15(10):879-89
pubmed: 11595084
J Trauma Stress. 2019 Aug;32(4):475-483
pubmed: 31283056
Psychol Med. 2008 Apr;38(4):533-42
pubmed: 17825121
J Med Internet Res. 2013 Aug 13;15(8):e165
pubmed: 23942480
Front Psychiatry. 2018 Nov 15;9:597
pubmed: 30498461
Med J Aust. 2013 Oct 21;199(8):S11-5
pubmed: 24138359
J Anxiety Disord. 2018 Dec;60:35-42
pubmed: 30419537
Eur J Psychotraumatol. 2018 Jun 14;9(1):1476442
pubmed: 29938009
J Physiol Paris. 2016 Nov;110(4 Pt B):453-460
pubmed: 28161453
J Consult Clin Psychol. 2000 Oct;68(5):748-66
pubmed: 11068961
Multivariate Behav Res. 2018 Mar-Apr;53(2):267-291
pubmed: 29324055
J Psychiatr Pract. 2015 Jul;21(4):281-303
pubmed: 26164054
J Psychiatr Res. 2014 Dec;59:68-76
pubmed: 25260752
Lancet Psychiatry. 2015 May;2(5):413-421
pubmed: 26360285
PLoS Med. 2014 Oct 14;11(10):e1001744
pubmed: 25314315
Biol Psychiatry. 2017 Jun 15;81(12):977-978
pubmed: 28554390
Nat Med. 2020 Jul;26(7):1084-1088
pubmed: 32632194
Curr Opin Psychol. 2017 Apr;14:132-137
pubmed: 28813312
Psychosom Med. 2017 Oct;79(8):936-946
pubmed: 28700459
Biol Psychiatry. 2018 May 15;83(10):792-794
pubmed: 29685184
J Trauma. 2001 Aug;51(2):287-92; discussion 292-3
pubmed: 11493786
Psychoneuroendocrinology. 2013 Nov;38(11):2520-8
pubmed: 23806832
Acad Emerg Med. 2020 Jan;27(1):71-79
pubmed: 31675448
PLoS One. 2013 Aug 22;8(8):e70084
pubmed: 23990895
Psychol Med. 2018 Oct;48(14):2409-2417
pubmed: 29486811
Gen Hosp Psychiatry. 2015 May-Jun;37(3):230-5
pubmed: 25805128
Psychoneuroendocrinology. 2018 Jan;87:35-42
pubmed: 29035710
BMJ. 2015 Nov 26;351:h6161
pubmed: 26611143
J Abnorm Psychol. 2019 Oct;128(7):645-657
pubmed: 31282686

Auteurs

Katharina Schultebraucks (K)

Vagelos School of Physicians and Surgeons, Department of Emergency Medicine, Columbia University Medical Center, New York, NY, United States of America; Data Science Institute, Columbia University, New York, New York, USA.

Marit Sijbrandij (M)

Vrije Universiteit, Department of Clinical, Neuro- and Developmental Psychology; Amsterdam Public Health Research Institute, World Health Organization Collaborating Centre for Research and Dissemination of Psychological Interventions, Amsterdam, the Netherlands.

Isaac Galatzer-Levy (I)

Department of Psychiatry, New York University School of Medicine, New York, New York, USA.

Joanne Mouthaan (J)

Department of Clinical Psychology, Institute of Psychology, Faculty of Social and Behavioural Sciences, Leiden University, Leiden, the Netherlands.

Miranda Olff (M)

ARQ National Psychotrauma Centre, Diemen, the Netherlands.
Department of Psychiatry, Amsterdam University Medical Centers, Location Amsterdam Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute and Amsterdam Neuroscience Research Institute, Amsterdam, the Netherlands.

Mirjam van Zuiden (M)

Department of Psychiatry, Amsterdam University Medical Centers, Location Amsterdam Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute and Amsterdam Neuroscience Research Institute, Amsterdam, the Netherlands.

Classifications MeSH